265 related articles for article (PubMed ID: 33211721)
1. Impaired arterial vitamin D signaling occurs in the development of vascular calcification.
Lim K; Molostvov G; Lubczanska M; Fletcher S; Bland R; Hiemstra TF; Zehnder D
PLoS One; 2020; 15(11):e0241976. PubMed ID: 33211721
[TBL] [Abstract][Full Text] [Related]
2. In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation.
Martínez-Moreno JM; Muñoz-Castañeda JR; Herencia C; Oca AM; Estepa JC; Canalejo R; Rodríguez-Ortiz ME; Perez-Martinez P; Aguilera-Tejero E; Canalejo A; Rodríguez M; Almadén Y
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1136-44. PubMed ID: 22874762
[TBL] [Abstract][Full Text] [Related]
3. Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification.
Han MS; Che X; Cho GH; Park HR; Lim KE; Park NR; Jin JS; Jung YK; Jeong JH; Lee IK; Kato S; Choi JY
PLoS One; 2013; 8(12):e83584. PubMed ID: 24349534
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin.
Li X; Speer MY; Yang H; Bergen J; Giachelli CM
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):321-6. PubMed ID: 19948844
[TBL] [Abstract][Full Text] [Related]
5. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.
Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL
Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells.
Martinez-Moreno JM; Herencia C; Montes de Oca A; Muñoz-Castañeda JR; Rodríguez-Ortiz ME; Díaz-Tocados JM; Peralbo-Santaella E; Camargo A; Canalejo A; Rodriguez M; Velasco-Gimena F; Almaden Y
FASEB J; 2016 Mar; 30(3):1367-76. PubMed ID: 26700731
[TBL] [Abstract][Full Text] [Related]
7. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2.
Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.
Lau WL; Leaf EM; Hu MC; Takeno MM; Kuro-o M; Moe OW; Giachelli CM
Kidney Int; 2012 Dec; 82(12):1261-70. PubMed ID: 22932118
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a.
Caus M; Alonso-Montes C; Fernandez-Martin JL; Marti-Antonio M; Bozic M; Valdivielso JM
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1533-1548. PubMed ID: 37381989
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells.
Wu-Wong JR; Nakane M; Ma J
Thromb Res; 2006; 118(6):709-14. PubMed ID: 16371233
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor activation and prevention of arterial ageing.
Cozzolino M; Stucchi A; Rizzo MA; Soldati L; Cusi D; Ciceri P; Brenna I; Elli F; Gallieni M
Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):547-52. PubMed ID: 22633189
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
[TBL] [Abstract][Full Text] [Related]
13. Vascular calcification in chronic kidney failure: role of vitamin D receptor.
Wu-Wong JR; Melnick J
Curr Opin Investig Drugs; 2007 Mar; 8(3):237-47. PubMed ID: 17408120
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
[TBL] [Abstract][Full Text] [Related]
15. TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.
Rayego-Mateos S; Morgado-Pascual JL; Valdivielso JM; Sanz AB; Bosch-Panadero E; Rodrigues-Díez RR; Egido J; Ortiz A; González-Parra E; Ruiz-Ortega M
J Am Soc Nephrol; 2020 Sep; 31(9):2026-2042. PubMed ID: 32631974
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies.
Brancaccio D; Bommer J; Coyne D
Drugs; 2007; 67(14):1981-98. PubMed ID: 17883283
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J
J Vasc Res; 2007; 44(1):11-8. PubMed ID: 17159355
[TBL] [Abstract][Full Text] [Related]
18. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
J Cell Biochem; 2007 Apr; 100(6):1395-405. PubMed ID: 17115413
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
Sawada K; Wu-Wong JR; Chen YW; Wessale JL; Kanai G; Kakuta T; Fukagawa M
J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin D receptor activator therapy on vitamin D receptor and osteocalcin expression in circulating endothelial progenitor cells of hemodialysis patients.
Cianciolo G; La Manna G; Della Bella E; Cappuccilli ML; Angelini ML; Dormi A; Capelli I; Laterza C; Costa R; Alviano F; Donati G; Ronco C; Stefoni S
Blood Purif; 2013; 35(1-3):187-95. PubMed ID: 23485859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
